| 期刊全称 | Bone Drugs in Pediatrics | | 期刊简称 | Efficacy and Challen | | 影响因子2023 | Gordon L. Klein | | 视频video | | | 发行地址 | Presents evidence for the use of certain drugs in the treatment and prevention of bone loss in children.Balances the pros and cons of utilizing these drugs in the pediatric population.Highlights the p | | 图书封面 |  | | 影响因子 | .Bone Drugs in Pediatrics. brings together in one place the evidence for the use of certain drugs in the treatment and prevention of bone loss in children, as well as the reservations still present in the pediatric community regarding their use. Beginning with a discussion of developmental pharmacokinetics and drug development for pediatric diseases where bone loss occurs, such as osteogenesis imperfecta, the physiology of pediatric bone and how best to monitor the safety and efficacy of these drugs is presented. The pros and cons of utilizing the drugs themselves – such as bisphosphonates, antiresorptives and anabolic agents – within the pediatric population are carefully considered, with an eye toward safe and effective integration. The potential use of drugs in future treatment is also highlighted. On the whole, .Bone Drugs in Pediatrics .is a cogent presentation of the ongoing debate surrounding the potential for pharmacological interventions in pediatric bone loss. | | Pindex | Book 2014 |
The information of publication is updating
|
|
发表于 2025-3-21 16:26:24
